Related Experiment Video
Updated: Aug 7, 2026

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)
Published on: April 19, 2013
Tumor-associated zinc finger mutations in the CTCF transcription factor selectively alter tts DNA-binding specificity
Galina N Filippova1, Chen-Feng Qi, Jonathan E Ulmer
1Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
Abstract:
CTCF is a widely expressed 11-zinc finger (ZF) transcription factor that is involved in different aspects of gene regulation including promoter activation or repression, hormone-responsive gene silencing, methylation-dependent chromatin insulation, and genomic imprinting. Because CTCF targets include oncogenes and tumor suppressor genes, we screened over 100 human tumor samples for mutations that might disrupt CTCF activity. We did not observe any CTCF mutations leading to truncations/premature stops. Rather, in breast, prostate, and Wilms' tumors, we observed four different CTCF somatic missense mutations involving amino acids within the ZF domain. Each ZF mutation abrogated CTCF binding to a subset of target sites within the promoters/insulators of certain genes involved in regulating cell proliferation but did not alter binding to the regulatory sequences of other genes. These observations suggest that CTCF may represent a novel tumor suppressor gene that displays tumor-specific "change of function" rather than complete "loss of function."
Insights
CTCF mutations in cancer alter gene regulation without causing complete loss of function. These specific changes suggest CTCF acts as a tumor suppressor with a modified role in certain cancers.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- CCCTC-binding factor (CTCF) is a crucial transcription factor regulating gene expression, chromatin insulation, and genomic imprinting.
- CTCF's role in regulating oncogenes and tumor suppressor genes makes it a candidate for cancer-related mutations.
Purpose of the Study:
- To investigate mutations in the CTCF gene within human tumor samples.
- To determine if identified mutations affect CTCF's DNA binding activity and gene regulatory functions.
Main Methods:
- Screening of over 100 human tumor samples for CTCF mutations.
- Analysis of missense mutations within the zinc finger (ZF) domain of CTCF.
- Assessment of CTCF binding affinity to target gene regulatory sequences.
Main Results:
- No truncating CTCF mutations were found; however, four distinct somatic missense mutations in the ZF domain were identified in breast, prostate, and Wilms' tumors.
- Each mutation selectively impaired CTCF binding to specific target sites involved in cell proliferation gene regulation.
- Binding to other CTCF target sites remained unaffected, indicating a partial loss of function.
Conclusions:
- CTCF mutations can lead to a "change of function" rather than a complete "loss of function" in tumor cells.
- CTCF may act as a novel tumor suppressor gene, with its altered activity contributing to specific cancer types.
Related Concept Videos
Transcription Factors
lncRNA - Long Non-coding RNAs
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...

